NASDAQ:VIVO
Delisted
Meridian Bioscience Inc. Stock News
$33.97
+0 (+0%)
At Close: Apr 28, 2023
Catalent (CTLT) to Report Q3 Earnings: What's in the Cards?
04:55pm, Monday, 25'th Apr 2022 Zacks Investment Research
Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.
Bio-Rad (BIO) to Report Q1 Earnings: What's in the Cards?
01:02pm, Monday, 25'th Apr 2022 Zacks Investment Research
Robust uptake of dPCR products and a rebound in routine testing are likely to have contributed to Bio-Rad's (BIO) first-quarter top line.
Fulgent Genetics (FLGT) to Post Q1 Earnings: What's in Store?
12:38pm, Monday, 25'th Apr 2022 Zacks Investment Research
Strategic investments and expanding operations in China are likely to have contributed to Fulgent Genetics' (FLGT) first-quarter performance.
LabCorp (LH) to Report Q1 Earnings: What's in the Cards?
03:22pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Robust base business growth and notable launches are likely to have contributed to LabCorp's (LH) Q1 performance.
Abiomed (ABMD) to Report Q4 Earnings: What's in the Cards?
03:16pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Continued strength in Abiomed's (ABMD) Impella product line is expected to have driven Q4 sales.
Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?
01:14pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Strength in Diagnostics and GYN Surgical businesses is likely to have contributed to Hologic's (HOLX) fiscal second-quarter revenues.
Align Technology (ALGN) to Post Q1 Earnings: What's in Store?
01:05pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Robust demand for iTero scanners and increasing Invisalign case submissions are expected to have contributed to Align Technology's (ALGN) Q1 performance.
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
03:00pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Given an innovative pipeline, expansion into faster growth markets, globalization efforts and enhanced digital capabilities, Boston Scientific (BSX) is well-positioned to register strong first quarter
Ecolab (ECL) to Report Q1 Earnings: What's in the Offing?
02:53pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Ecolab's (ECL) first-quarter results are likely to reflect continued strength across its business segments.
Abbott's (ABT) Q1 Earnings and Revenues Exceed Estimates
02:23pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Within Adult Nutrition, Abbott (ABT) gains from the strong performance of Ensure and Glucerna brands in Q1.
Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?
12:48pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Robust global demand for Oncotype DX and increased Cologuard orders are likely to have driven Exact Sciences' (EXAS) Q1 performance.
Edwards Lifesciences (EW) to Post Q1 Earnings: What's in Store?
12:47pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) first-quarter performance.
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
01:20pm, Monday, 18'th Apr 2022 Zacks Investment Research
Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the continuous rollout of Alinity, Abbott's suite of diagnostic instru
Quest Diagnostics (DGX) Q1 Earnings to Grow on Base Business
01:03pm, Monday, 18'th Apr 2022 Zacks Investment Research
Quest Diagnostics (DGX) is expected to report a strong first half of Q1 with a growing number of cases and then a dull second half on gradual stabilization in testing demand.
Zacks.com featured highlights include Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group
12:06pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group are part of Screen of the Week article.
